Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant

Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant

The immunity potency upon natural infection or vaccination is the main concern for the vaccine strategy of severe acute respiratory syndrome coronavirus 2（SARS COV-2 variant）, especially the recently reported Omicron variant (B.1.1.529). In this study, 200 recipients immunized with three doses of a...

Full description

Bibliographic Details
Main Authors: Xiaoling Yu, Xiangrong Qi, Yu Cao, Peiyao Li, Li Lu, Pingping Wang, Yuchen Feng, Jie Yang, Huihui Wei, Lixian Guo, Mingyue Sun, Qiang Liu, Jing Lv, Yingmei Feng
Format: Article
Language:English
Published: Taylor & Francis Group 2022-02-01
Series:Emerging Microbes and Infections
Subjects:
omicron variant
sarscov-2
vaccine
neutralizing antibody
Online Access:http://dx.doi.org/10.1080/22221751.2022.2044271

Similar Items

Similar Items